{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:21:22Z","timestamp":1779913282626,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1124\/mol.52.3.380","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T20:27:48Z","timestamp":1515443268000},"page":"380-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Cerebellar \u03b3-Aminobutyric Acid Type A Receptors: Pharmacological Subtypes Revealed by Mutant Mouse Lines"],"prefix":"10.1016","volume":"52","author":[{"given":"Riikka","family":"M\u00e4kel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Uusi-Oukari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg E.","family":"Homanics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard L.","family":"Firestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wisden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa R.","family":"Korpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.52.3.380_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0031-6997(25)06840-1","article-title":"Structure and pharmacology of \u03b3-aminobutyric acidA receptor subtypes.","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1124\/mol.52.3.380_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1124\/mol.52.3.380_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/385820a0","article-title":"Insensitivity to anaesthetic agents conferred by a class of GABAA receptor subunit.","volume":"385","author":"Davies","year":"1997","journal-title":"Nature (Lond.)"},{"key":"10.1124\/mol.52.3.380_bib4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/346648a0","article-title":"Cerebellar GABAA receptor selective for a behavioural alcohol antagonist.","volume":"346","author":"L\u00fcddens","year":"1990","journal-title":"Nature (Lond.)"},{"key":"10.1124\/mol.52.3.380_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cne.903390304","article-title":"GABAA\/benzodiazepine receptor \u03b16 subunit mRNA in granule cells of the cerebellar cortex and cochlear nuclei: expression in developing and mutant mice.","volume":"339","author":"Varecka","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1124\/mol.52.3.380_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0028-3908(96)00076-7","article-title":"The cerebellum: a model system for studying GABAA receptor diversity.","volume":"35","author":"Wisden","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.52.3.380_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1471-4159.1987.tb13125.x","article-title":"Photoaffinity labeling of benzodiazepine receptor proteins with the partial inverse agonist [3H]Ro 15\u20134513: a biochemical and autoradiographic study.","volume":"48","author":"Sieghart","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1124\/mol.52.3.380_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(89)90816-9","article-title":"Diazepam-insensitive [3H]Ro 15\u20134513 binding in intact cultured cerebellar granule cells.","volume":"169","author":"Malminiemi","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0026-895X(25)13177-5","article-title":"Regional \u03b3-aminobutyric acid sensitivity of t-butylbicyclophosphoro[35S]thionate binding depends on \u03b3-aminobutyric acidA receptor \u03b1 subunit.","volume":"44","author":"Korpi","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0026-895X(25)08539-6","article-title":"Selective antagonist for the cerebellar granule cell-specific \u03b3-aminobutyric acid type A receptor.","volume":"47","author":"Korpi","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1523\/JNEUROSCI.16-01-00103.1996","article-title":"The \u03b16 subunit of the GABAA receptor is concentrated in both inhibitory and excitatory synapses on cerebellar granule cells.","volume":"16","author":"Nusser","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1124\/mol.52.3.380_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0026-895X(25)09148-5","article-title":"\u03b16 and \u03b32 subunit antisense oligodeoxynucleotides alter \u03b3-aminobutyric acid receptor pharmacology in cerebellar neurons.","volume":"50","author":"Zhu","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib13","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1523\/JNEUROSCI.16-21-06648.1996","article-title":"\u03b4 Subunit inhibits neurosteroid modulation of GABAA receptors.","volume":"16","author":"Zhu","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1124\/mol.52.3.380_bib14","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1523\/JNEUROSCI.17-04-01350.1997","article-title":"Ligand-gated ion channel subunit partnerships: GABAA receptor \u03b16 subunit gene inactivation inhibits \u03b4 subunit expression.","volume":"17","author":"Jones","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1124\/mol.52.3.380_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/mol.51.4.588","article-title":"Gene knockout of the \u03b16 subunit of the \u03b3-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics.","volume":"51","author":"Homanics","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-3565(25)24693-6","article-title":"The benzodiazepine\/alcohol antagonist Ro-15\u20134513: binding to a GABAA receptor subtype that is insensitive to diazepam.","volume":"257","author":"Turner","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1124\/mol.52.3.380_bib17","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1046\/j.1471-4159.1996.66051810.x","article-title":"Conservation of \u03b3-aminobutyric acid type A receptor \u03b16 subunit gene expression in cerebellar granule cells.","volume":"66","author":"Bahn","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1124\/mol.52.3.380_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0026-895X(25)08706-1","article-title":"Cloning of cDNAs encoding the human \u03b3-aminobutyric acid type A receptor \u03b16 subunit and characterization of the pharmacology of \u03b16-containing receptors.","volume":"49","author":"Hadingham","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib19","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1046\/j.1471-4159.1996.66052179.x","article-title":"Modulation of GABAA receptor tert-[35S]butylbicyclophosphorothionate binding by antagonists: relationship to patterns of subunit expression.","volume":"66","author":"Korpi","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1124\/mol.52.3.380_bib20","first-page":"59","article-title":"GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system.","volume":"3","author":"Olsen","year":"1990","journal-title":"J. Chem. Neuroanat."},{"key":"10.1124\/mol.52.3.380_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0091-3057(95)02076-4","article-title":"Pharmacologic actions of subtype-selective and novel GABAergic ligands in rat lines with differential sensitivity to ethanol.","volume":"53","author":"Wong","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1124\/mol.52.3.380_bib22","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1460-9568.1994.tb00598.x","article-title":"Radioautographic evidence that the GABAA receptor antagonist SR 95531 is a substrate inhibitor of MAO-A in the rat and human locus coeruleus.","volume":"6","author":"Luque","year":"1994","journal-title":"Eur. J. Neurosci."},{"key":"10.1124\/mol.52.3.380_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-6147(91)90495-E","article-title":"Function and pharmacology of multiple GABAA receptor subunits.","volume":"12","author":"L\u00fcddens","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1124\/mol.52.3.380_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.pa.22.040182.001333","article-title":"Drug interactions at the GABA receptor-ionophore complex.","volume":"22","author":"Olsen","year":"1982","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1124\/mol.52.3.380_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0006-8993(86)91158-3","article-title":"Biochemical characterization of the interaction of three pyridazinyl-GABA derivatives with the GABAA receptor site.","volume":"384","author":"Heaulme","year":"1986","journal-title":"Brain Res."},{"key":"10.1124\/mol.52.3.380_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0922-4106(95)00061-5","article-title":"Characterization of \u03b4-subunit containing GABAA receptors from rat brain.","volume":"290","author":"Quirk","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0896-6273(90)90337-F","article-title":"Functional and molecular distinction between recombinant rat GABAA receptor subtypes by Zn2+.","volume":"5","author":"Draguhn","year":"1990","journal-title":"Neuron"},{"key":"10.1124\/mol.52.3.380_bib28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0026-895X(25)08745-0","article-title":"Properties of putative cerebellar \u03b3-aminobutyric acidA receptor isoforms.","volume":"49","author":"Saxena","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1471-4159.1994.62020602.x","article-title":"Zinc inhibition of t-[3H]butylbicycloorthobenzoate binding to the GABAA receptor complex.","volume":"62","author":"Kume","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1124\/mol.52.3.380_bib30","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1073\/pnas.91.10.4569","article-title":"The modulatory action of loreclezole at the \u03b3-aminobutyric acid type A receptor is determined by a single amino acid in the \u03b22 and \u03b23 subunit.","volume":"91","author":"Wingrove","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.3.380_bib31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0026-895X(25)10583-X","article-title":"\u03b2-Carboline \u03b3-aminobutyric acidA receptor inverse agonists modulate \u03b3-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site.","volume":"48","author":"Stevenson","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib32","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0021-9258(18)45961-3","article-title":"A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.","volume":"267","author":"Wieland","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1124\/mol.52.3.380_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-3565(25)24354-3","article-title":"\u03b3-Aminobutyric acid gating of Cl\u2212 channels in recombinant GABAA receptors.","volume":"272","author":"Ducic","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1124\/mol.52.3.380_bib34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1471-4159.1996.66020685.x","article-title":"The \u03b11 and \u03b16 subunits can coexist in the same cerebellar GABAA receptor maintaining their individual benzodiazepine-binding specificities.","volume":"66","author":"Khan","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1124\/mol.52.3.380_bib35","doi-asserted-by":"crossref","first-page":"16020","DOI":"10.1016\/S0021-9258(17)33967-4","article-title":"Model of subunit composition of \u03b3-aminobutyric acid A receptor subtypes expressed in rat cerebellum with respect to their \u03b1 and \u03b3\/\u03b4 subunits.","volume":"269","author":"Quirk","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1124\/mol.52.3.380_bib36","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.12-03-01040.1992","article-title":"The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon.","volume":"12","author":"Wisden","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1124\/mol.52.3.380_bib37","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1523\/JNEUROSCI.12-03-01063.1992","article-title":"The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum.","volume":"12","author":"Laurie","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1124\/mol.52.3.380_bib38","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0028-3908(96)00086-X","article-title":"The \u03b32 subunit of the GABAA receptor is concentrated in synaptic junctions containing the \u03b11 and \u03b22\/3 subunits in hippocampus, cerebellum and globus pallidus.","volume":"35","author":"Somogyi","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.52.3.380_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0922-4106(93)90056-F","article-title":"Triazolam is more efficacious than diazepam in a broad spectrum of recombinant GABAA receptors.","volume":"244","author":"Ducic","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1124\/mol.52.3.380_bib40","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1523\/JNEUROSCI.14-05-02503.1994","article-title":"Developmental regulation of voltage-gated K+ channel and GABAA receptor expression in Bergmann glial cells.","volume":"14","author":"M\u00fcller","year":"1994","journal-title":"J. Neurosci."}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24133378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24133378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.52.3.380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:05:43Z","timestamp":1740045943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24133378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["S0026895X24133378"],"URL":"https:\/\/doi.org\/10.1124\/mol.52.3.380","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[1997,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebellar \u03b3-Aminobutyric Acid Type A Receptors: Pharmacological Subtypes Revealed by Mutant Mouse Lines","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.52.3.380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 1997 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}